Provided by Tiger Trade Technology Pte. Ltd.

Tredegar

7.77
+0.10001.30%
Post-market: 7.770.00000.00%17:44 EDT
Volume:92.37K
Turnover:713.18K
Market Cap:271.26M
PE:9.30
High:7.78
Open:7.75
Low:7.61
Close:7.67
52wk High:10.53
52wk Low:6.25
Shares:34.91M
Float Shares:27.37M
Volume Ratio:0.78
T/O Rate:0.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.8353
EPS(LYR):0.9604
ROE:13.72%
ROA:5.94%
PB:1.21
PE(LYR):8.09

Loading ...

Analysts Offer Insights on Healthcare Companies: TG Therapeutics (TGTX), Syndax Pharmaceuticals (SNDX) and DaVita (DVA)

TIPRANKS
·
Yesterday

TG Therapeutics Earnings Call Signals BRIUMVI Surge

TIPRANKS
·
Yesterday

TG Metals Plans Share and Option Issue to Bolster Capital Base

TIPRANKS
·
Aug 04

TG Metals raises A$2.5 million to drive gold and lithium project development

TIPRANKS
·
Aug 04

TG Therapeutics Down over 11%, on Pace for Largest Percent Decrease Since August 2025

Dow Jones
·
Aug 04

TG Therapeutics falls -10.6%

TIPRANKS
·
Aug 04

Press Release: Tredegar Plans to Release Second Quarter 2026 Financial Results on August 7, 2026

Dow Jones
·
Aug 03

Earnings Flash (TGTX) TG Therapeutics Posts Q2 EPS $0.05, vs. FactSet Est of $0.31

MT Newswires Live
·
Aug 03

TG Therapeutics Q2 EPS $0.05 Misses $0.33 Estimate, Sales $240.335M Beat $229.721M Estimate

Benzinga Earnings
·
Aug 03

TG Therapeutics Reports Second Quarter 2026 Financial Results and Raises BRIUMVI® Revenue Guidance

GlobeNewswire
·
Aug 03

TG Metals boosts Van Uden gold resources and advances lithium development

TIPRANKS
·
Jul 31

TG Metals Seeks ASX Trading Halt Ahead of Capital Raising Announcement

TIPRANKS
·
Jul 31

Tredegar CEO, Treasurer, VP Frasier Brickhouse II retiring in September

TIPRANKS
·
Jul 31

Tredegar CFO Frasier Brickhouse to Retire Effective Sept. 1, 2026

Reuters
·
Jul 31

Tredegar Announces the Retirement of Frasier W. Brickhouse Ii, Chief Financial Officer, Treasurer and Vice President, Effective September 1, 2026

THOMSON REUTERS
·
Jul 31

This TG Metals Insider Reduced Their Stake By 100%

Simply Wall St.
·
Jul 29

TG Therapeutics is Maintained at Buy by B. Riley Securities

Dow Jones
·
Jul 28

B. Riley Raises Price Target on TG Therapeutics to $86 From $55, Keeps Buy Rating

MT Newswires Live
·
Jul 27

Medallion Metals, TG Metals Sign Ore Processing Agreement for Van Uden Gold Stockpiles

MT Newswires Live
·
Jul 22

TG Metals Strikes Profit-Share Ore Deal for Van Uden Stockpiles

TIPRANKS
·
Jul 22